Metraipolis › archive › dc_c816c79f129d

Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42396448
DOI
10.3389/fimmu.2026.1844666
License (as archived)
solo-consultazione
Archived
2026-10-31T09:44:16.394Z
SHA-256 of the archived text
a94c156b212496e1654b7dfa650d77edf536a4c9d65f8de64876b027c9358cc5
Stable URL of this page
https://metraipolis.com/documento/dc_c816c79f129d

How to cite

Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448 — Europe PMC (en), https://europepmc.org/article/MED/42396448 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c816c79f129d (Metraipolis archive dc_c816c79f129d, sha256 a94c156b212496e1654b7dfa650d77edf536a4c9d65f8de64876b027c9358cc5)
BibTeX
@misc{dcc816c79f129d,
  title = {Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center… — Europe PMC PMID:42396448},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42396448},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c816c79f129d; sha256 a94c156b212496e1654b7dfa650d77edf536a4c9d65f8de64876b027c9358cc5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42396448. Agents can read the archived copy with the MCP tool read_document.